Pfizer Inc. 13D and 13G filings for 4D Molecular Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-11 3:54 pm Sale |
2021-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
PFIZER INC PFE |
341,658 1.060% |
-1,325,000 (-79.50%) |
Filing |
| 2021-02-12 6:37 pm Purchase |
2020-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
PFIZER INC PFE |
1,666,658 6.300% |
1,666,658 (New Position) |
Filing |